Clinical Trial Update: Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating biomarkers for response to aflibercept in Asian patients with diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Diabetic Macular Edema | Phase 4 | Status: UNKNOWN